Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » Most recent entries » Horizons in World Cardiovascular Research. Volume 2 Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Medicaid Fraud Control: Integrity Efforts in Selected States
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Beneficial Clinical Effects of Perhexiline in Cardiac Patients: Multiple Biochemical Mechanisms, pp. 1-27
Tell A Friend
Tell someone you know about this product.
Beneficial Clinical Effects of Perhexiline in Cardiac Patients: Multiple Biochemical Mechanisms, pp. 1-27 $100.00
Authors:  (Yuliy Y. Chirkov, Aaron L. Sverdlov, John D. Horowitz, Basil Hetzel Institute, The Queen Elizabeth Hospital/Dept. of Medicine, The University of Adelaide, Australia)
Perhexiline, 2-(2,2-dicyclohexylethyl)piperidine, was originally developed as a prophylactic anti-anginal drug in the late 1960s. It was initially a popular and effective treatment for angina, having the almost unique property compared to other agents available at that time, of not inducing reductions in blood pressure or heart rate. Despite the initial success, its use diminished markedly due to the occurrence during long-term therapy of poorly understood side effects (neurotoxicity and hepatotoxicity), which later were shown to be associated with high plasma concentrations of perhexiline, occurring in patients with relatively slow hepatic metabolism of the drug. However, therapeutic plasma monitoring and associated dose adjustments have led to perhexiline's reintroduction into clinical practice. Recent clinical data have proved its safety and
maintained efficacy. Perhexiline reduced anginal frequency in patients with refractory angina. In patients with chronic heart failure, perhexiline improved peak exercise oxygen consumption, left ventricular ejection fraction, symptoms, resting and peak stress
myocardial function. Perhexiline also appears to be effective in suppressing symptoms in patients with acute coronary syndromes or with advanced and inoperable aortic valvular stenosis. Herein we discuss perhexiline's pharmacology with particular emphasis on its
mechanism(s) of action. 

Available Options:
Special Focus Titles
01.Land Use, Land-Use Change and Forestry
02.Wildland Fires: A Worldwide Reality
03.Amazonian Resources: Microbiota, Fauna and Flora
04.Forensic Psychiatry: A Public Health Perspective
05.Religion and Health: The Perspective of Happy Science Medicine
06.Neurobiology of Men's Mental Health
07.Pediatric Diabetic Ketoacidosis: Risk Factors and Pathophysiology, Management Strategies and Outcomes
08.Integrated Psychological Services in Primary Care
09.Heterotopic Ossification: Basic Science, General Principles, and Clinical Correlates in Orthopedic Surgery
10.Glioblastoma Multiforme: Symptoms, Diagnosis, Therapeutic Management and Outcome
11.A Primer for Swimming Coaches. Volume 1: Physiological Foundations
12.Marsupials and Monotremes: Nature’s Enigmatic Mammals

Nova Science Publishers
© Copyright 2004 - 2015

Beneficial Clinical Effects of Perhexiline in Cardiac Patients: Multiple Biochemical Mechanisms, pp. 1-27